28May

Semaglutide demonstrated superior glycaemic control vs insulin glargine U100 in ... Read more

24May

IDegLira receives positive 16-0 vote in favour of approval from FDA Advisory Com ... Read more

20May

FDA posts briefing materials prior to Advisory Committee meeting for IDegLira, a ... Read more

16May

Novo Nordisk files for regulatory approval in the US of long-acting factor IX fo ... Read more

30May

Novo Nordisk A/S - Share repurchase programme ... Read more

24May

IDegLira receives positive 16-0 vote in favour of approval from FDA Advisory Com ... Read more

20May

FDA posts briefing materials prior to Advisory Committee meeting for IDegLira, a ... Read more

19May

Novo Nordisk A/S - Share repurchase programme ... Read more

01June

Danske Bank Navigating the Nordics, Stockholm

07June

Jefferies Global Healthcare Conference, New York

08June

Goldman Sachs Annual Global Healthcare Conference, Los Angeles

09June

Barclays European Select Conference, NAPA Valley

 

 

 

Investors

 
Share information


Take an advanced view of the Novo Nordisk share

 
Investor call on sustainability
 
Q1 financial results


Access the Q1 material



Novo Nordisk at a glance


Private shareholders


See relevant content for private investors



IR material


Download relevant Investor Relations material



Contacts



Subscriptions


Sign up to receive company announcements.



Annual Report 2015


Download the Novo Nordisk Annual Report 2015